- Home
- TWIN vs FENC Comparison
TWIN vs FENC Comparison
Compare TWIN & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- FENC
- Stock Information
- Founded
- TWIN 1918
- FENC 1996
- Country
- TWIN United States
- FENC United States
- Employees
- TWIN N/A
- FENC N/A
- Industry
- TWIN Industrial Machinery/Components
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TWIN Industrials
- FENC Health Care
- Exchange
- TWIN Nasdaq
- FENC Nasdaq
- Market Cap
- TWIN 97.0M
- FENC 229.8M
- IPO Year
- TWIN N/A
- FENC 2001
- Fundamental
- Price
- TWIN $8.73
- FENC $8.34
- Analyst Decision
- TWIN Strong Buy
- FENC Strong Buy
- Analyst Count
- TWIN 1
- FENC 2
- Target Price
- TWIN $12.00
- FENC $13.00
- AVG Volume (30 Days)
- TWIN 154.6K
- FENC 83.2K
- Earning Date
- TWIN 08-14-2025
- FENC 08-12-2025
- Dividend Yield
- TWIN 1.82%
- FENC N/A
- EPS Growth
- TWIN N/A
- FENC N/A
- EPS
- TWIN 0.29
- FENC N/A
- Revenue
- TWIN $328,478,000.00
- FENC $30,912,000.00
- Revenue This Year
- TWIN $27.91
- FENC $0.85
- Revenue Next Year
- TWIN N/A
- FENC $55.16
- P/E Ratio
- TWIN $30.14
- FENC N/A
- Revenue Growth
- TWIN 11.49
- FENC N/A
- 52 Week Low
- TWIN $6.16
- FENC $3.96
- 52 Week High
- TWIN $14.98
- FENC $8.72
- Technical
- Relative Strength Index (RSI)
- TWIN 70.14
- FENC 58.31
- Support Level
- TWIN $7.43
- FENC $7.53
- Resistance Level
- TWIN $9.05
- FENC $8.68
- Average True Range (ATR)
- TWIN 0.38
- FENC 0.49
- MACD
- TWIN 0.13
- FENC -0.04
- Stochastic Oscillator
- TWIN 84.97
- FENC 63.18
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.